Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy.

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for: Processed-food

HEALTH-CORONAVIRUS/USA
RTX859IU
October 27, 2020
Grocery worker Jackie Mayoral, 55, (C), who survived COVID-19 pauses for a moment of silence in front...
Los Angeles, UNITED STATES
Grocery worker Jackie Mayoral, pauses for a moment of silence in front of a Dia de los Muertos, Day of...
Grocery worker Jackie Mayoral, 55, (C), who survived COVID-19 pauses for a moment of silence in front of a Dia de los Muertos, Day of the Dead, altar honoring 1,308 UFCW Local 770 grocery, drug store, and food processing essential union workers who have died from the coronavirus disease (COVID-19), in Los Angeles, California, U.S., October 26, 2020. REUTERS/Lucy Nicholson
HEALTH-CORONAVIRUS/USA
RTX859IT
October 27, 2020
A Dia de los Muertos, Day of the Dead, altar honoring 1,308 UFCW Local 770 grocery, drug store, and food...
Los Angeles, UNITED STATES
A Dia de los Muertos, Day of the Dead, altar honoring 1,308 UFCW Local 770 grocery, drug store, and food...
A Dia de los Muertos, Day of the Dead, altar honoring 1,308 UFCW Local 770 grocery, drug store, and food processing essential union workers who have died from the coronavirus disease (COVID-19), is seen in Los Angeles, California, U.S., October 26, 2020. REUTERS/Lucy Nicholson
HEALTH-CORONAVIRUS/USA
RTX859IS
October 27, 2020
A Dia de los Muertos, Day of the Dead, altar honoring 1,308 UFCW Local 770 grocery, drug store, and food...
Los Angeles, UNITED STATES
A Dia de los Muertos, Day of the Dead, altar honoring 1,308 UFCW Local 770 grocery, drug store, and food...
A Dia de los Muertos, Day of the Dead, altar honoring 1,308 UFCW Local 770 grocery, drug store, and food processing essential union workers who have died from the coronavirus disease (COVID-19), is seen in Los Angeles, California, U.S., October 26, 2020. REUTERS/Lucy Nicholson
HEALTH-CORONAVIRUS/USA
RTX859IF
October 27, 2020
A Dia de los Muertos, Day of the Dead, altar honoring 1,308 UFCW Local 770 grocery, drug store, and food...
Los Angeles, UNITED STATES
A Dia de los Muertos, Day of the Dead, altar honoring 1,308 UFCW Local 770 grocery, drug store, and food...
A Dia de los Muertos, Day of the Dead, altar honoring 1,308 UFCW Local 770 grocery, drug store, and food processing essential union workers who have died from the coronavirus disease (COVID-19), is seen in Los Angeles, California, U.S., October 26, 2020. REUTERS/Lucy Nicholson
FRANCE-INSECT/FARM
RTX84N2H
October 24, 2020
Containers for mealworms are seen during the feeding process at the insect farm Ynsect, which harvests...
DOLE, France
French start-up Ynsect plans to build world's biggest bug farm
Containers for mealworms are seen during the feeding process at the insect farm Ynsect, which harvests mealworms for bug-based animal food and fertilizer, in Dole, France, October 22, 2020. Picture taken October 22, 2020. REUTERS/Ardee Napolitano
HEALTH-CORONAVIRUS/CHINA-PLANT-BASED-MEAT
RTX7VN1Y
September 15, 2020
A food scientist rolls texturized vegetable protein, which is the base of the plant-based meat products...
Beijing, China
A food scientist rolls texturized vegetable protein, which is the base of the plant-based meat products...
A food scientist rolls texturized vegetable protein, which is the base of the plant-based meat products offered by Zhenmeat, during a demonstration for the media of the production process in a lab at the Chinese Academy of Agricultural Sciences in Beijing, China September 5, 2020. Picture taken September 5, 2020. REUTERS/Carlos Garcia Rawlins
HEALTH-CORONAVIRUS/CHINA-PLANT-BASED-MEAT
RTX7VN1W
September 15, 2020
A food scientist grabs a roll of texturized vegetable protein, which is the base of the plant-based meat...
Beijing, China
A food scientist grabs a roll of texturized vegetable protein, which is the base of the plant-based meat...
A food scientist grabs a roll of texturized vegetable protein, which is the base of the plant-based meat products offered by Zhenmeat, during a demonstration for the media of the production process in a lab at the Chinese Academy of Agricultural Sciences in Beijing, China September 5, 2020. Picture taken September 5, 2020. REUTERS/Carlos Garcia Rawlins
HEALTH-CORONAVIRUS/CHINA-PLANT-BASED-MEAT
RTX7VN1D
September 15, 2020
A food scientist rolls texturized vegetable protein, which is the base of the plant-based meat products...
Beijing, China
A food scientist rolls texturized vegetable protein, which is the base of the plant-based meat products...
A food scientist rolls texturized vegetable protein, which is the base of the plant-based meat products offered by Zhenmeat, during a demonstration for the media of the production process in a lab at the Chinese Academy of Agricultural Sciences in Beijing, China September 5, 2020. Picture taken September 5, 2020. REUTERS/Carlos Garcia Rawlins
HEALTH-CORONAVIRUS/CHINA-PLANT-BASED-MEAT
RTX7VN19
September 15, 2020
A food scientist rolls texturized vegetable protein, which is the base of the plant-based meat products...
Beijing, China
A food scientist rolls texturized vegetable protein, which is the base of the plant-based meat products...
A food scientist rolls texturized vegetable protein, which is the base of the plant-based meat products offered by Zhenmeat, during a demonstration for the media of the production process in a lab at the Chinese Academy of Agricultural Sciences in Beijing, China September 5, 2020. Picture taken September 5, 2020. REUTERS/Carlos Garcia Rawlins
HEALTH-CORONAVIRUS/CHINA-PLANT-BASED-MEAT
RTX7VMCF
September 15, 2020
A food scientist rolls texturized vegetable protein, which is the base of the plant-based meat products...
Beijing, China
A food scientist rolls texturized vegetable protein, which is the base of the plant-based meat products...
A food scientist rolls texturized vegetable protein, which is the base of the plant-based meat products offered by Zhenmeat, during a demonstration for the media of the production process in a lab at the Chinese Academy of Agricultural Sciences in Beijing, China September 5, 2020. Picture taken September 5, 2020. REUTERS/Carlos Garcia Rawlins
HEALTH-CORONAVIRUS/CHINA-PLANT-BASED-MEAT
RTX7VMCB
September 15, 2020
A food scientist rolls texturized vegetable protein, which is the base of the plant-based meat products...
Beijing, China
A food scientist rolls texturized vegetable protein, which is the base of the plant-based meat products...
A food scientist rolls texturized vegetable protein, which is the base of the plant-based meat products offered by Zhenmeat, during a demonstration for the media of the production process in a lab at the Chinese Academy of Agricultural Sciences in Beijing, China September 5, 2020. Picture taken September 5, 2020. REUTERS/Carlos Garcia Rawlins
HEALTH-CORONAVIRUS/CHINA-PLANT-BASED-MEAT
RTX7VMC5
September 15, 2020
A food scientist grabs a roll of texturized vegetable protein, which is the base of the plant-based meat...
Beijing, China
A food scientist grabs a roll of texturized vegetable protein, which is the base of the plant-based meat...
A food scientist grabs a roll of texturized vegetable protein, which is the base of the plant-based meat products offered by Zhenmeat, during a demonstration for the media of the production process in a lab at the Chinese Academy of Agricultural Sciences in Beijing, China September 5, 2020. Picture taken September 5, 2020. REUTERS/Carlos Garcia Rawlins
HEALTH-CORONAVIRUS/CHINA-PLANT-BASED-MEAT
RTX7VMC4
September 15, 2020
A food scientist rolls texturized vegetable protein, which is the base of the plant-based meat products...
Beijing, China
A food scientist rolls texturized vegetable protein, which is the base of the plant-based meat products...
A food scientist rolls texturized vegetable protein, which is the base of the plant-based meat products offered by Zhenmeat, during a demonstration for the media of the production process in a lab at the Chinese Academy of Agricultural Sciences in Beijing, China September 5, 2020. Picture taken September 5, 2020. REUTERS/Carlos Garcia Rawlins
HEALTH-CORONAVIRUS/CHINA-PEPSICO
RTS3F1CH
June 22, 2020
A man wearing a face mask is seen at a booth at the entrance to a Pepsico food-processing plant in Beijing's...
Beijing, China
Man wearing a face mask is seen at a booth at the entrance to a Pepsico food-processing plant in Beijing...
A man wearing a face mask is seen at a booth at the entrance to a Pepsico food-processing plant in Beijing's Daxing district, following a new outbreak of the coronavirus disease (COVID-19), in China June 22, 2020. REUTERS/Tingshu Wang
HEALTH-CORONAVIRUS/CHINA-PEPSICO
RTS3F1B5
June 22, 2020
A Pepsico sign is seen at its food-processing plant in Beijing's Daxing district, following a new outbreak...
Beijing, China
A Pepsico sign is seen at its food-processing plant in Beijing's Daxing district, following a new outbreak...
A Pepsico sign is seen at its food-processing plant in Beijing's Daxing district, following a new outbreak of the coronavirus disease (COVID-19), China June 22, 2020. REUTERS/Tingshu Wang
HEALTH-CORONAVIRUS/CHINA-PEPSICO
RTS3F1B3
June 22, 2020
A Pepsico sign is seen at its food-processing plant near a surveillance camera in Beijing's Daxing district,...
Beijing, China
Pepsico sign is seen at its food-processing plant near a surveillance camera in Beijing's Daxing district,...
A Pepsico sign is seen at its food-processing plant near a surveillance camera in Beijing's Daxing district, following a new outbreak of the coronavirus disease (COVID-19), China June 22, 2020. REUTERS/Tingshu Wang
HEALTH-CORONAVIRUS/CHINA-PEPSICO
RTS3F1B2
June 22, 2020
A Pepsico sign is seen at its food-processing plant in Beijing's Daxing district, following a new outbreak...
Beijing, China
Pepsico sign is seen at its food-processing plant in Beijing's Daxing district, following a new outbreak...
A Pepsico sign is seen at its food-processing plant in Beijing's Daxing district, following a new outbreak of the coronavirus disease (COVID-19), China June 22, 2020. REUTERS/Tingshu Wang
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6UG
June 02, 2020
Deputy Director for Regulatory Programs, Center for Drug Evaluation and Research Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Deputy Director for Regulatory Programs, Center for Drug Evaluation and Research Food and Drug Administration, Douglas Throckmorton speaks by video conference during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6U9
June 02, 2020
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6U5
June 02, 2020
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6U0
June 02, 2020
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6TX
June 02, 2020
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo looks on during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6TW
June 02, 2020
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6QO
June 02, 2020
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration (FDA) speaks via teleconference during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6QN
June 02, 2020
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration (FDA) speaks via teleconference during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6QL
June 02, 2020
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listens during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6QK
June 02, 2020
United States Senator Tom Carper (Democrat of Delaware), center, speaks to Judith McMeekin, Associate...
Washington, United States of America
Senate Finance Committee
United States Senator Tom Carper (Democrat of Delaware), center, speaks to Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration FDA), before leaving the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6QI
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA),...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6QB
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA),...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6Q8
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA),...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6Q7
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA),...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6Q2
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA)...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA) listens during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6PR
June 02, 2020
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin and Associate Commissioner for Global Policy and Strategy, Food and Drug Administration, Mark Abdoo look on during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6PQ
June 02, 2020
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin and Associate Commissioner for Global Policy and Strategy, Food and Drug Administration, Mark Abdoo look on during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6PO
June 02, 2020
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin looks on as Associate Commissioner for Global Policy and Strategy, Food and Drug Administration, Mark Abdoo speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6P6
June 02, 2020
US Deputy Director for Regulatory Programs of the Center for Drug Evaluation and Research at the Food...
Washington, UNITED STATES
Senate Finance Committee
US Deputy Director for Regulatory Programs of the Center for Drug Evaluation and Research at the Food and Drug Administration, Douglas Throckmorton speaks by video conference during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6LC
June 02, 2020
Mary Denigan-Macauley, Ph.D., Director of Health Care at the United States Government Accountability...
Washington, United States of America
Senate Finance Committee
Mary Denigan-Macauley, Ph.D., Director of Health Care at the United States Government Accountability Office, left, speaks via teleconference as Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6LB
June 02, 2020
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration (FDA) speaks via teleconference as United States Senator Todd Young (Republican of Indiana) looks over notes during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6L9
June 02, 2020
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration (FDA) speaks via teleconference during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6L8
June 02, 2020
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration (FDA) speaks via teleconference during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6L0
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA)...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA) speaks during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KZ
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA)...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA) speaks during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KY
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA),...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KX
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA),...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KT
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA),...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KR
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA)...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA) speaks during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KL
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA)...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA) speaks during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KK
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA)...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA) looks over notes during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KH
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA)...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA) speaks during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KG
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA)...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA) listens during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6K6
June 02, 2020
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA) speaks during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6K3
June 02, 2020
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA) speaks during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6JX
June 02, 2020
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA) listens during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6JT
June 02, 2020
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration...
Washington, United States of America
U.S. Senate Hearing: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA) listens during the United States Senate Committee on Finance hearing regarding the inspection process of foreign drug manufacturing on Capitol Hill in Washington D.C., U.S., on Tuesday, June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6JS
June 02, 2020
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA) listens during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6JR
June 02, 2020
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA) listens during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6HS
June 02, 2020
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin and Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration Mark Abdoo look on during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6G7
June 02, 2020
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6G3
June 02, 2020
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6G2
June 02, 2020
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
Sort by
Display
Items per page
Page
of 35